Is it just me or does it look like GILD is trying to find a tradeable low here? It's been performing like shit but I'm going to keep an eye on it. At some point it might want to mean revert to the 200MA.
Adage Capital Partners GP LLC Dissolves Share Stake In Moderna, Takes In Gilead Sciences!
Germany requests 5% of EU supply of remdesivir
Germany has requested around 5% of the supply of remdesivir under a six-month European Union supply deal, its health ministry said on Monday, despite criticism of the deal due to a lack of evidence about the...
Earlier this year there was the question : How do you invest in Coronavirus vaccine stocks?
Now, we have the answer : YOU DONT.
Chart looking bleak, and the support lines are weak. This could be due to a few reasons:
- Lack of MAINSTREAM updates
- NVAX actually has no other vaccines
- Market volatility due to covid and elections
- Investors are seeking less...
We maybe have finished movement inside this monthly downward channel, which looks like a corrective channel for previous bullish impulse. Chances are we will go north from here. But if price will brake this channel downwards it may as well become ugly, and there is no support levels, I guess?
Anyway, now GILD highly tightened to SNP and thus electional uncertainty.
I also wrote on the huge upside potential of Gilead when they acquired Immunomedics for $21 billion.
The acquisition expands Gilead's portfolio of treatments for various types of cancer.
On 9/10/2020 Oppenheimer Brokerage Boosted Price Target to Outperform from...
see charts at www.tradingview.com
$DGX Entry 120
Target 1 $125
Target 2 $130
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
With Covid wave 2 on the rise, this could be a huge player.
What is DGX?
Quest Diagnostics is an American clinical...
see full chart at www.tradingview.com
Entry $62 area
Target 1 $67
Target 2 $71
Why this play?
Trump used Gild's drug as part of his treatment, if he pulls thru with a full recovery. they will probably start pumping the news about this company and it'll finally have enough momentum to move back to the upside.
TRUMP PUMP! Gild on high watch with Trump receiving REMDISIVIR treatment and Trump reporting he is feeling better and expected to be discharged and return soon. Which means we could see green market this week. GILD is at my support zone and we have a gap up to fill at $69 If we can hold above $61.62 we could see a move back up to fill that gap. Good opportunity to...
The acquisition will expand Gilead's portfolio of treatments for various types of cancer.
The deal with Immunomedics provides Gilead (GILD) with Trodelvy, an antibody drug for advanced triple-negative breast cancer. The drug was given accelerated FDA approval in April. (Source CNN Business).
Sell on 1 hour chart
Buy on 7h chart
Sell on 3 day chart, but a trend...
we're still holding GILD and now it's making another attempt at recovering from the recent drop
we need to break the $67 and stay above it for couple of sessions - with strong volume - to flag a proper recovery - the prior attempt for a breakout failed - this time there's some momentum and demand - but still light.